Ogivri Drug Interactions
Currently displaying 117 drugs known to have a moderate interaction with Ogivri (trastuzumab).
- 54 major drug interactions
- 117 moderate drug interactions
Moderate interactions with Ogivri (trastuzumab)
Note: Showing generic names only.
A
B
C
- canakinumab
- candida albicans extract
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- coccidioidin skin test
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
D
E
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
I
- idelalisib
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
J
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lyme disease vaccine
M
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mixed respiratory vaccine
- monomethyl fumarate
- mumps skin test antigen
N
O
P
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegfilgrastim
- pertussis, acellular
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- rilonacept
- roflumilast
- ropeginterferon alfa-2b
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
S
- saccharomyces boulardii lyo
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- sodium phosphate p32
- staphage lysate (spl)
- streptococcus salivarius
T
- tbo-filgrastim
- tetanus toxoid
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- topotecan
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
U
V
W
Z
Ogivri alcohol/food interactions
There is 1 alcohol/food interaction with Ogivri (trastuzumab).
Ogivri disease interactions
There are 4 disease interactions with Ogivri (trastuzumab) which include:
More about Ogivri (trastuzumab)
- Ogivri consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.